Profiel
Brett L.
Schmidli has been Senior Vice President of Technical Operations for Protein Design Labs, Inc. since February 2002.
He was Director of Manufacturing Strategy for Eli Lilly & Co. from 2000 to 2002 and Chief Operating Officer and Director of Commercial Development from 1998 to 2000.
He was Director of Manufacturing and Product Development for Eli Lilly & Co. from 1995 to 1998 and Director of Bioproducts Purification Development and Technical Services from 1992 to 1995.
He was an Officer of Genetics Institute, Inc. from 1982 to 1987 and Senior Consultant from 1987 to 1989.
He received a Bachelor's degree from the Rose-Hulman Institute of Technology and an MBA from Indiana University.
Eerdere bekende functies van Brett L. Schmidli
| Bedrijven | Functie | Einde |
|---|---|---|
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Hoofd Techniek/Wetenschap/O&O | 10-01-2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-01-2002 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-1989 |
Opleiding van Brett L. Schmidli
| Rose-Hulman Institute of Technology, Inc. | Undergraduate Degree |
| Indiana University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
